Gaelle Pierron
Gaelle Pierron
PhD. Responsable Adjoint Unité Génétique Somatique Institut Curie Paris
Verified email at
Cited by
Cited by
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
I Janoueix-Lerosey, D Lequin, L Brugieres, A Ribeiro, L De Pontual, ...
Nature 455 (7215), 967-970, 2008
Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 MutationsComprehensive Genomic Analysis of Ewing Sarcoma
F Tirode, D Surdez, X Ma, M Parker, MC Le Deley, A Bahrami, Z Zhang, ...
Cancer discovery 4 (11), 1342-1353, 2014
Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma
D Williamson, E Missiaglia, A de Reynies, G Pierron, B Thuille, ...
J Clin Oncol 28 (13), 2151-2158, 2010
A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion
G Pierron, F Tirode, C Lucchesi, S Reynaud, S Ballet, S Cohen-Gogo, ...
Nature genetics 44 (4), 461-466, 2012
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
V Boeva, C Louis-Brennetot, A Peltier, S Durand, C Pierre-Eugène, ...
Nature genetics 49 (9), 1408-1413, 2017
PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification
E Missiaglia, D Williamson, J Chisholm, P Wirapati, G Pierron, F Petel, ...
J Clin Oncol 30 (14), 1670-1677, 2012
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
R Lebofsky, C Decraene, V Bernard, M Kamal, A Blin, Q Leroy, TR Frio, ...
Molecular oncology 9 (4), 783-790, 2015
Impact of EWS-ETS fusion type on disease progression in Ewing’s sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-EWING 99 trial
MC Le Deley, O Delattre, KL Schaefer, SA Burchill, G Koehler, ...
J Clin Oncol 28 (12), 1982-8, 2010
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
F Le Loarer, S Watson, G Pierron, VT de Montpreville, S Ballet, N Firmin, ...
Nature genetics 47 (10), 1200-1205, 2015
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity
A Vincent-Salomon, N Gruel, C Lucchesi, G MacGrogan, R Dendale, ...
Breast Cancer Research 9 (2), 1-15, 2007
Transcriptomic definition of molecular subgroups of small round cell sarcomas
S Watson, V Perrin, D Guillemot, S Reynaud, JM Coindre, M Karanian, ...
The Journal of pathology 245 (1), 29-40, 2018
Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor
F Bourdeaut, D Lequin, L Brugières, S Reynaud, C Dufour, F Doz, ...
Clinical Cancer Research 17 (1), 31-38, 2011
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
NC Sheffield, G Pierron, J Klughammer, P Datlinger, A Schönegger, ...
Nature medicine 23 (3), 386-395, 2017
Emergence of new ALK mutations at relapse of neuroblastoma
G Schleiermacher, N Javanmardi, V Bernard, Q Leroy, J Cappo, TR Frio, ...
J Clin Oncol 32 (25), 2727-2734, 2014
High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors
E Manié, A Vincent-Salomon, J Lehmann-Che, G Pierron, E Turpin, ...
Cancer research 69 (2), 663-671, 2009
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
S Postel-Vinay, AS Véron, F Tirode, G Pierron, S Reynaud, H Kovar, ...
Nature genetics 44 (3), 323-327, 2012
Two types of chromosome 1p losses with opposite significance in gliomas
A Idbaih, Y Marie, G Pierron, C Brennetot, K Hoang‐Xuan, M Kujas, ...
Annals of neurology 58 (3), 483-487, 2005
Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast
A Vincent-Salomon, C Lucchesi, N Gruel, V Raynal, G Pierron, ...
Clinical cancer research 14 (7), 1956-1965, 2008
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
TGP Grünewald, V Bernard, P Gilardi-Hebenstreit, V Raynal, D Surdez, ...
Nature genetics 47 (9), 1073-1078, 2015
Accumulation of segmental alterations determines progression in neuroblastoma
G Schleiermacher, I Janoueix-Lerosey, A Ribeiro, J Klijanienko, ...
Journal of Clinical Oncology 28 (19), 3122-3130, 2010
The system can't perform the operation now. Try again later.
Articles 1–20